Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014
Froestl, Wolfgang; Pfeifer, Andrea; Muhs, Andreas
2014

Abstract

Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers, are very productive. The review "Drugs interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs" was accepted in October 2012. In the last 20 months, new targets for the potential treatment of Alzheimer's disease were identified. Enormous progress was realized in the pharmacological characterization of natural products with cognitive enhancing properties. This review covers the evolution of research in this field through May 2014.

Details

Title Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014
Author(s) Froestl, Wolfgang ; Pfeifer, Andrea ; Muhs, Andreas
Published in Journal Of Alzheimers Disease
Pagination 71
Volume 42
Issue 4
Pages 1079-1149
Date 2014
Publisher Amsterdam, Ios Press
ISSN 1387-2877
Keywords
DOI https://doi.org/10.3233/Jad-141206
Other identifier(s) View record in Web of Science
Laboratories ISIC-GE
Record Appears in Scientific production and competences > SB - School of Basic Sciences > ISIC - Institute of Chemical Sciences and Engineering > ISIC-GE - Institute of Chemical Sciences and Engineering
Peer-reviewed publications
Work produced at EPFL
Published
Reviews
Record creation date 2014-12-30

Actions